1James S. McKinney,William J. Kostis.Statin Therapy and the Risk of Intracerebral Hemorrhage: A Meta-Analysis of 31 Randomized Controlled Trials[J]. Stroke . 2012 (8) 被引量：2
2Paul M Ridker,Aruna Pradhan,Jean G MacFadyen,Peter Libby,Robert J Glynn.Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial[J]. The Lancet . 2012 (9841) 被引量：2
3Evan A. Stein,Donald G. Vidt,James Shepherd,Valerie A. Cain,Deborah Anzalone,Michael D. Cressman.Renal safety of intensive cholesterol-lowering treatment with rosuvastatin: A retrospective analysis of renal adverse events among 40,600 participants in the rosuvastatin clinical development program[J]. Atherosclerosis . 2012 (2) 被引量：2
4Samia Mora,Nanette K. Wenger,David A. DeMicco,Andrei Breazna,S. Matthijs Boekholdt,Benoit J. Arsenault,Prakash Deedwania,John J.P. Kastelein,David D. Waters.Determinants of Residual Risk in Secondary Prevention Patients Treated With High- Versus Low-Dose Statin Therapy: The Treating to New Targets (TNT) Study[J]. Circulation . 2012 (16) 被引量：1
5Daniel G. Hackam,Mark Woodward,L. Kristin Newby,Deepak L. Bhatt,Mingyuan Shao,Eric E. Smith,Allan Donner,Muhammad Mamdani,James D. Douketis,Hisatomi Arima,John Chalmers,Stephen MacMahon,David L. Tirschwell,Bruce M. Psaty,Cheryl D. Bushnell,Maria I. Aguilar,Dan J. Capampangan,David J. Werring,Paola De Rango,Anand Viswanathan,Nicolas Danchin,Ching-Lan Cheng,Yea-Huei Kao Yang,B. Marianne Verdel,Mei-Shu Lai,James Kennedy,Shinichiro Uchiyama,Takenori Yamaguchi,Yasuo Ikeda,Marko Mrkobrada.Statins and Intracerebral Hemorrhage: Collaborative Systematic Review and Meta-Analysis[J]. Circulation . 2011 (20) 被引量：1
6Naveed Sattar,David Preiss,Heather M Murray,Paul Welsh,Brendan M Buckley,Anton JM de Craen,Sreenivasa Rao Kondapally Seshasai,John J McMurray,Dilys J Freeman,J Wouter Jukema,Peter W Macfarlane,Chris J Packard,David J Stott,Rudi G Westendorp,James Shepherd,Barry R Davis,Sara L Pressel,Roberto Marchioli,Rosa Maria Marfisi,Aldo P Maggioni,Luigi Tavazzi,Gianni Tognoni,John Kjekshus,Terje R Pedersen,Thomas J Cook,Antonio M Gotto,Michael B Clearfield,John R Downs,Haruo Nakamura,Yasuo Ohashi,Kyoichi Mizuno,Kausik K Ray,Ian Ford.Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials[J]. The Lancet . 2010 (9716) 被引量：1
7L B. Goldstein,P Amarenco,M Szarek,A Callahan,M Hennerici,H Sillesen,J A. Zivin,K M.A. Welch.Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study[J]. Neurology . 2008 (24,) 被引量：1
8Alawi A. Alsheikh-Ali,Prasad V. Maddukuri,Hui Han,Richard H. Karas.Effect of the Magnitude of Lipid Lowering on Risk of Elevated Liver Enzymes, Rhabdomyolysis, and Cancer[J]. Journal of the American College of Cardiology . 2007 (5) 被引量：1
9Michael H. Davidson,John A. Clark,Lucas M. Glass,Anju Kanumalla.Statin Safety: An Appraisal from the Adverse Event Reporting System[J]. The American Journal of Cardiology . 2006 (8) 被引量：1
10The Stroke Prevention by Aggressive Reduction in CholesterolLevels(SPARCL)Investigators:high-dose atorvastatin after strokeor transient ischemic attack. The New England Journal of Medicine . 2006 被引量：1
